| ADCC | antibody-dependent cell-mediated cytotoxicity |
| APCs | antigen-presenting cells |
| Cat | cathepsin |
| CatG | cathepsin G |
| CCL1 | chemokine C-C motif ligand 1 |
| CSPG4 | chondroitin sulfate proteoglycan 4 |
| DCs | dendritic cells |
| D-MMSN | doxorubicin-loaded magnetic mesoporous silica nanoparticles |
| DNAM-1 | DNAX accessory molecule 1 |
| DNRII | TGF-β-dominant-negative receptor II |
| EGFR | epidermal growth factor receptor |
| EGFRvIII | epidermal growth factor receptor variant III |
| GM-CSF | granulocyte macrophage colony-stimulating factor |
| HLA | human leukocyte antigen |
| IL-2 | interleukin 2 |
| ITAM | immunoreceptor tyrosine-based activation motif |
| KIRs | killer immunoglobulin-like receptors |
| MDSCs | myeloid-derived suppressor cells |
| MHC I | major histocompatibility complex class I |
| NETs | neutrophil extracellular traps |
| MICA | MHC class I chain-related protein A |
| MICB | MHC class I chain-related protein B |
| NCR | natural cytotoxicity receptor |
| NK cells | natural killer cells |
| NKG2D | natural killer group 2D activating receptor |
| NKG2DL | natural killer group 2D ligands |
| NSPs | neutrophil serine proteases |
| PBMCs | peripheral blood mononuclear cells |
| TCR | T cell receptor |
| TGF-β | transforming growth factor beta |
| TGN | trans-Golgi network |
| Th cells | T helper cells |
| TME | tumor microenvironment |
| TNF-α | tumor necrosis factor α |
| TRAIL | TNF-related apoptosis-inducing ligand |
| Tregs | T regulatory cells |
| ULBP1–6 | UL 16 binding protein 1–6 |